1 |
#Year Text 1 Text 2 Text 3 Text 4 Text 5 |
2 |
1 1921 in Karlovac, companies "Chinoin" from Budapest and "Isis" from Zagreb found "Kaptel" d.d., the predecessor of today's PLIVA |
3 |
5 1935 organised research starts in "Kaptel" with the arrival of Nobel Prize winner dr. Vladimir Prelog |
4 |
10 1936 "Kaptel" d.d. becomes one of the first producers of sulphonamides in the world |
5 |
15 1952 PLIVA Research Institute was founded |
6 |
20 1953 the first production of Vitamin C using its own technology |
7 |
25 1959 oxytetracycline and Vitamin B6 production starts |
8 |
30 1971 metacycline patented |
9 |
35 1980 PLIVA's own original macrolide antibiotic patented - called azithromycin, which lists Croatia among the 9 countries world-wide that have their own antibiotic substance |
10 |
40 1986 PLIVA signs azithromycin license agreement with "Pfizer", according to which PFIZER gets exclusive sales rights for US and Western Europe |
11 |
45 1988 azithromycin launched under brand name SUMAMED |
12 |
50 1991 PFIZER launches azithromycin under brand name ZITHROMAX |
13 |
55 1996 listing of PLIVA's shares on London and Zagreb Stock Exchange |
14 |
60 1997 acquisition of PLIVA Krakow |
15 |
65 1998 new azithromycin production facility was open |
16 |
70 1999 acquisition of FARMACOM acquisition of MIXIS GENETICS Ltd. |
17 |
75 1999 acquisition of LACHEMA |
18 |
80 2000 acquisition of Dominion |